202 related articles for article (PubMed ID: 12407636)
1. Safety and efficacy of sodium ferric gluconate complex in patients with chronic kidney disease.
Panesar A; Agarwal R
Am J Kidney Dis; 2002 Nov; 40(5):924-31. PubMed ID: 12407636
[TBL] [Abstract][Full Text] [Related]
2. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
[TBL] [Abstract][Full Text] [Related]
3. Sodium ferric gluconate complex in hemodialysis patients: adverse reactions compared to placebo and iron dextran.
Michael B; Coyne DW; Fishbane S; Folkert V; Lynn R; Nissenson AR; Agarwal R; Eschbach JW; Fadem SZ; Trout JR; Strobos J; Warnock DG;
Kidney Int; 2002 May; 61(5):1830-9. PubMed ID: 11967034
[TBL] [Abstract][Full Text] [Related]
4. The comparative safety of various intravenous iron preparations in chronic kidney disease patients.
Anirban G; Kohli HS; Jha V; Gupta KL; Sakhuja V
Ren Fail; 2008; 30(6):629-38. PubMed ID: 18661414
[TBL] [Abstract][Full Text] [Related]
5. Sodium ferric gluconate complex therapy in anemic children on hemodialysis.
Warady BA; Zobrist RH; Wu J; Finan E;
Pediatr Nephrol; 2005 Sep; 20(9):1320-7. PubMed ID: 15971073
[TBL] [Abstract][Full Text] [Related]
6. Sodium ferric gluconate complex in hemodialysis patients. II. Adverse reactions in iron dextran-sensitive and dextran-tolerant patients.
Coyne DW; Adkinson NF; Nissenson AR; Fishbane S; Agarwal R; Eschbach JW; Michael B; Folkert V; Batlle D; Trout JR; Dahl N; Myirski P; Strobos J; Warnock DG;
Kidney Int; 2003 Jan; 63(1):217-24. PubMed ID: 12472786
[TBL] [Abstract][Full Text] [Related]
7. [Iron replacement in hemodialysis patients with a normal serum ferritin level].
Riedel MK; Morgenstern T
Dtsch Med Wochenschr; 2004 Sep; 129(36):1849-53. PubMed ID: 15368155
[TBL] [Abstract][Full Text] [Related]
8. Iron sucrose with and without recombinant erythropoietin for the treatment of severe postpartum anemia: a prospective, randomized, open-label study.
Krafft A; Breymann C
J Obstet Gynaecol Res; 2011 Feb; 37(2):119-24. PubMed ID: 21159035
[TBL] [Abstract][Full Text] [Related]
9. Sodium ferric gluconate complex in sucrose is safe and effective in hemodialysis patients: North American Clinical Trial.
Nissenson AR; Lindsay RM; Swan S; Seligman P; Strobos J
Am J Kidney Dis; 1999 Mar; 33(3):471-82. PubMed ID: 10070911
[TBL] [Abstract][Full Text] [Related]
10. Randomized evaluation of efficacy and safety of ferric carboxymaltose in patients with iron deficiency anaemia and impaired renal function (REPAIR-IDA): rationale and study design.
Szczech LA; Bregman DB; Harrington RA; Morris D; Butcher A; Koch TA; Goodnough LT; Wolf M; Onken JE
Nephrol Dial Transplant; 2010 Jul; 25(7):2368-75. PubMed ID: 20466657
[TBL] [Abstract][Full Text] [Related]
11. Darbepoetin alfa administered every other week maintains hemoglobin levels over 52 weeks in patients with chronic kidney disease converting from once-weekly recombinant human erythropoietin: results from simplify the treatment of anemia with Aranesp (STAAR).
Hertel J; Locay H; Scarlata D; Jackson L; Prathikanti R; Audhya P
Am J Nephrol; 2006; 26(2):149-56. PubMed ID: 16636531
[TBL] [Abstract][Full Text] [Related]
12. A randomized, controlled parallel-group trial on efficacy and safety of iron sucrose (Venofer) vs iron gluconate (Ferrlecit) in haemodialysis patients treated with rHuEpo.
Kosch M; Bahner U; Bettger H; Matzkies F; Teschner M; Schaefer RM
Nephrol Dial Transplant; 2001 Jun; 16(6):1239-44. PubMed ID: 11390726
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of intravenously administered iron sucrose with and without adjuvant recombinant human erythropoietin for the treatment of resistant iron-deficiency anemia during pregnancy.
Breymann C; Visca E; Huch R; Huch A
Am J Obstet Gynecol; 2001 Mar; 184(4):662-7. PubMed ID: 11262469
[TBL] [Abstract][Full Text] [Related]
14. A randomized controlled trial of oral versus intravenous iron in chronic kidney disease.
Agarwal R; Rizkala AR; Bastani B; Kaskas MO; Leehey DJ; Besarab A
Am J Nephrol; 2006; 26(5):445-54. PubMed ID: 17035697
[TBL] [Abstract][Full Text] [Related]
15. Sodium ferric gluconate complex in haemodialysis patients: a prospective evaluation of long-term safety.
Michael B; Coyne DW; Folkert VW; Dahl NV; Warnock DG;
Nephrol Dial Transplant; 2004 Jun; 19(6):1576-80. PubMed ID: 15034152
[TBL] [Abstract][Full Text] [Related]
16. Intravenous iron in chronic kidney disease: haemoglobin change shortly after treatment of patients neither on dialysis nor on erythropoietin.
Tagboto S; Cropper L; Mostafa S; Turner J; Bailey G; Pugh-Clarke K
J Ren Care; 2008 Sep; 34(3):112-5. PubMed ID: 18786076
[TBL] [Abstract][Full Text] [Related]
17. Lipid peroxidation products formation with various intravenous iron preparations in chronic kidney disease.
Ganguli A; Kohli HS; Khullar M; Lal Gupta K; Jha V; Sakhuja V
Ren Fail; 2009; 31(2):106-10. PubMed ID: 19212906
[TBL] [Abstract][Full Text] [Related]
18. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron.
Gotloib L; Silverberg D; Fudin R; Shostak A
J Nephrol; 2006; 19(2):161-7. PubMed ID: 16736414
[TBL] [Abstract][Full Text] [Related]
19. Intravenous ferric carboxymaltose versus standard medical care in the treatment of iron deficiency anemia in patients with chronic kidney disease: a randomized, active-controlled, multi-center study.
Charytan C; Bernardo MV; Koch TA; Butcher A; Morris D; Bregman DB
Nephrol Dial Transplant; 2013 Apr; 28(4):953-64. PubMed ID: 23222534
[TBL] [Abstract][Full Text] [Related]
20. Sodium ferric gluconate complex maintenance therapy in children on hemodialysis.
Warady BA; Zobrist RH; Finan E;
Pediatr Nephrol; 2006 Apr; 21(4):553-60. PubMed ID: 16520948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
